MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/90/0.1/20.12.24 Stock

Warrant

DE000MG4D260

Real-time Bid/Ask 04:41:43 2024-07-03 EDT
0.25 EUR / 0.33 EUR +16.00% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/90/0.1/20.12.24
1 month-75.49%
Date Price Change
24-07-02 0.25 -13.79%
24-07-01 0.29 +16.00%
24-06-28 0.25 -10.71%
24-06-27 0.28 +12.00%
24-06-26 0.25 -3.85%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 02:52 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D26
ISINDE000MG4D260
Date issued 2024-05-16
Strike 90 $
Maturity 2024-12-20 (171 Days)
Parity 10 : 1
Emission price 1.99
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.01
Lowest since issue 0.24
Delta0.24x
Omega 4.600
Premium62.65x
Gearing19.34x
Moneyness 0.6350
Difference Strike 32.76 $
Difference Strike %+36.40%
Spread 0.03
Spread %10.34%
Theoretical value 0.2900
Implied Volatility 67.95 %
Total Loss Probability 87.56 %
Intrinsic value 0.000000
Present value 0.2900
Break even 93.12 €
Theta-0.02x
Vega0.01x
Rho0x

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus